glp 1 antidiabetic Frontiers Glucagon-Like Peptide-1 Based Therapies: A

Read or listen now!

GLP-1 receptor agonists have shown cardiovascular benefits beyond weight loss, including potential improvements in cholesterol profiles

Barrons characterized the announcement that the company would offering weight-loss injections for as low as $199 a month via its telehealth platform as Hims taking on Big Pharma with cheap obesity shots. Those cheap shots will run about one-seventh of the list price of Novo Nordisks Wegovy which is priced about $1,349 a month

New lower price for a limited time only

There is a growing call for policies to improve access to these potentially life-changing treatments

Future research should focus on elucidating the complex mechanisms underlying their psychological effects and integrating mental health considerations into therapeutic strategies